Anthropic S-1 promises scientific breakthroughs—and new threats

In its IPO filing, Anthropic warns that while its AI tools could help discover new disease treatments, its safeguards are "incomplete" against bad actors who might use them to create biological weapons.

• Anthropic calls its biosecurity safeguards "incomplete"
• Company touts AI-driven scientific discovery
• Risks disclosed in S-1 ahead of IPO